Back to all bills
Standard Summary
Comprehensive overview in 1-2 paragraphs
Senate version of the Alternatives to PAIN Act to ensure Medicare Part D access to non-opioid pain management drugs without cost barriers or utilization management restrictions.
Key Points
- 1Eliminates deductibles for qualifying non-opioid pain management drugs
- 2Places qualifying drugs on lowest cost-sharing tier
- 3Prohibits step therapy requiring opioids before non-opioid alternatives
- 4Prohibits prior authorization requirements for qualifying drugs
- 5Applies to plan years beginning January 1, 2026
- 6Defines qualifying drugs as FDA-approved for acute pain without opioid receptors
Impact Areas
Medicare Part D beneficiariesNon-opioid pain management drug accessOpioid crisis preventionPharmaceutical coverage policiesPain management treatment optionsMedicare prescription drug program
Generated by kwaipilot/kat-coder-pro:free on Nov 21, 2025